January 24, 2017
Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of&he...
Read More
January 26, 2016
NYT: Parents of Children With Rare Diseases Find Hope in For-Profit Companies
Read More
October 30, 2015
RARECast: Gene Therapy Company Born from Mother’s Quest to Cure Daughter
Read More
May 18, 2013
Lysogene Recieves US Orphan Designation for its Lead Intracerebral Gene Therapy Product SAF-301
Read More
February 28, 2013
Lysogene Unveils New Website Dedicated to Patients, Their Families and Patient Organizations
Read More